Organization (Nonprofit)
Arbor Research Collaborative for Health
ClinicalTrials.gov lists Arbor Research Collaborative for Health as lead sponsor of 19 trials. It has 1 active development program.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Arbor Research Collaborative for Health: 19 lead-sponsored trials and 1 legal-entity registration.
Disease areas (27)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Cholestasis | 4 |
| Fibrosis | 4 |
| Renal Insufficiency, Chronic | 4 |
| Biliary Atresia | 3 |
| Urinary Bladder, Overactive | 3 |
Showing 5 of 27 disease areas.
Trials by start year as sponsor or collaborator (15)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 1 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 3 |
| 2013 | 2 |
| 2011 | 1 |
Showing 10 of 15 years.
Recruitment duration, a model prediction: none of the 19 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (1)
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Observational | Urinary Bladder, Overactive | Not reported | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 4 hit target (n=4) | 20% on time (n=5) |
Journals published in (62)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society | 13 |
| American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 12 |
| Hepatology (Baltimore, Md.) | 10 |
| Journal of pediatric gastroenterology and nutrition | 10 |
| Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 9 |
Showing 5 of 62 journals.
Financing and grant events (14)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2025-09-02 | NIH grant | 998,039 | Reporter |
| 2024-07-12 | NIH grant | 170,171 | Reporter |
| 2024-07-10 | NIH grant | 659,999 | Reporter |
| 2023-08-09 | NIH grant | 1,047,930 | Reporter |
| 2022-09-06 | NIH grant | 1,064,951 | Reporter |
Showing 5 of 14 events.
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| American Society of Transplant Surgeons | Co sponsors trial with | 1 |
Latest dated events (35)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-02-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-02 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2024-07-12 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2024-07-10 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2023-08-09 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
Showing 5 of 35 events.
Biomarker capability evidence (46)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ATM | Trial sponsor | Named in trial inclusion criteria |
| BRCA1 | Trial sponsor | Named in trial inclusion criteria |
| BRCA2 | Trial sponsor | Named in trial inclusion criteria |
| CDKN2A | Trial sponsor | Named in trial inclusion criteria |
| EPCAM | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 46 evidence rows.
Biomarkers this organization publishes on (3)
Shown in this order: most publications first.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, us granted patents, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.